colon

Liquid biopsy can save colon cancer patients from chemotherapy

Liquid biopsy can save colon cancer patients from chemotherapy

CHICAGO – Early colon cancer patients who have been found circulating tumor DNA in their blood may need more aggressive treatment, but people who have a negative liquid biopsy seem safe to avoid chemotherapy – without an increased risk of recurrence, the researchers suggested. . About 28% of patients diagnosed with stage II colon cancer …

Liquid biopsy can save colon cancer patients from chemotherapy Read More »

ctDNA has been shown to be effective as a treatment decision tool for adjuvant chemotherapy in colon cancer

ctDNA has been shown to be effective as a treatment decision tool for adjuvant chemotherapy in colon cancer

Controlled approaches using circulating tumor DNA can reduce the number of patients receiving adjuvant chemotherapy without the risk of reducing recurrence-free survival in some patients with stage II colon cancer. Controlled approaches using circulating tumor DNA (ctDNA) may, according to the DYNAMIC Phase 2 study, reduce the number of patients receiving adjuvant chemotherapy without the …

ctDNA has been shown to be effective as a treatment decision tool for adjuvant chemotherapy in colon cancer Read More »